Stayble Therapeutics terminates agreement regarding liquidity provider
Stayble Therapeutics AB ("Stayble" or "the Company") announces today that the Company has terminated the agreement regarding the liquidity provider with Lago Kapital AB ("Lago"). The agreement will cease to be effective on September 29, 2023.The purpose of the liquidity provider has been to increase the liquidity of stock trading and reduce the volatility of the Company's stock to facilitate trading. Stayble assesses that the liquidity of the stock is strong and that the need for a liquidity provider is no longer applicable. The agreement with Lago has now been terminated and will expire on